Target Name: MIR1469
NCBI ID: G100302258
Review Report on MIR1469 Target / Biomarker Content of Review Report on MIR1469 Target / Biomarker
MIR1469
Other Name(s): hsa-miR-1469 | hsa-mir-1469 | MIRN1469 | microRNA 1469 | MicroRNA 1469

MIR1469: A Drug Target / Disease Biomarker

MIR1469 is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the miRNA-protein complex, which plays a critical role in regulating gene expression and cell function. Several studies have identified MIR1469 as a potential drug target or biomarker, with potential therapeutic applications in a range of diseases.

The miRNA-protein complex is a large family of non-coding RNAs that play a central role in post-transcriptional gene regulation. This complex includes several subunits, including MIR1469, which is composed of a unique combination of 122 amino acid residues. MIR1469 is expressed in a variety of tissues and has been shown to play a role in several cellular processes, including cell signaling, cell cycle progression, and tissue repair.

One of the defining features of MIR1469 is its ability to interact with other proteins in the cell. Several studies have shown that MIR1469 can form complexes with various cellular components, including other proteins that are involved in cell signaling pathways. These interactions can modulate the activity of MIR1469 and affect its function in the cell.

In addition to its role in cellular signaling, MIR1469 has also been shown to play a critical role in the development and progression of several diseases. Several studies have shown that MIR1469 is overexpressed in a variety of cancer types, including breast, ovarian, and colorectal cancers. This overexpression is associated with poor prognosis and therapeutic resistance to traditional cancer therapies.

Another potential application of MIR1469 is its potential as a biomarker for certain diseases. Several studies have shown that MIR1469 can be used as a diagnostic marker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This uses of MIR1469 as a biomarker are based on the fact that MIR1469 is expressed in a variety of tissues and that its expression can be modulated by different factors, including disease-specific genetic and environmental triggers.

In addition to its potential as a drug target or biomarker, MIR1469 is also of interest from a fundamental scientific perspective. The study of miRNA-protein interactions and their role in cellular signaling pathways is an rapidly growing field of research, and MIR1469 is an important player in this field. The continued characterization of MIR1469 and its role in cellular signaling and disease will likely have a significant impact on our understanding of these processes and their implications for human health.

In conclusion, MIR1469 is a protein that has significant potential as a drug target or biomarker. Its ability to interact with other proteins and its role in cellular signaling pathways make it an attractive target for therapeutic intervention. Furthermore, its potential as a biomarker for disease makes it an important tool for the diagnosis and treatment of certain diseases. Further research is needed to fully understand the function of MIR1469 and its potential implications for human health.

Protein Name: MicroRNA 1469

The "MIR1469 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1469 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B